About: Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 17 March 2010

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2010 (fr) наукова стаття, опублікована в травні 2010 (uk) im Mai 2010 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 17 March 2010 (en) artículu científicu espublizáu en marzu de 2010 (ast)
publication date	wds:Q59649562-82120D5D-3DDB-48E0-B35D-F960DA1AFBED
publication date	2010-03-17 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59649562-0DBBA88E-FF56-4728-81B0-8BA6F560665F
language of work or name	English
cites work	wds:Q59649562-9378E769-AF5D-470F-A665-63CDDB3EE4C3
cites work	Cancer statistics, 2009
author name string	wds:Q59649562-25EA50E0-76AA-429A-9FE8-13CC2B29095F wds:Q59649562-CEE5C4E7-9838-4153-97F0-210B5DD35CF8
author name string	Amit Gupta Ramy F Youssef
rdfs:label	Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers (en) Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers (nl)
skos:prefLabel	Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers (en) Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers (nl)
name	Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers (en) Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers (nl)
author	wds:Q59649562-2304ACF3-CACE-45BB-A676-9582C9F8CDD9 wds:Q59649562-25764997-C521-4151-9823-2CCD5842E12D wds:Q59649562-A8E1FBE4-D959-4B3C-A765-F0742D9450CA wds:Q59649562-ABC346EC-3DCD-4BFB-BB41-BBCD346EDBD4 wds:Q59649562-C23F37AE-D01F-4EAF-B360-925ED87ABF12 wds:Q59649562-C460A484-8507-4846-BE08-D2141E52775A wds:Q59649562-C56390EA-314A-48A8-8B73-C782B3717458 wds:Q59649562-DDABBFC2-45B0-4EC6-BB0A-633BC145B778
author	Shahrokh Shariat Daher C Chade Pierre I Karakiewicz Raheela Ashfaq Yair Lotan Claudio Jeldres Hendrik Isbarn Arthur I. Sagalowsky
title	wds:Q59649562-BE0F4B01-8075-48EE-B692-80CF4B1099E4
title	Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers (en)
page(s)	wds:Q59649562-7E76A764-4079-4C80-BA45-4ED58D54CE37
page(s)	1744-1750
instance of	wds:Q59649562-00ADA3A5-A84E-4017-AB6D-FDFDD4BE3F07
instance of	scholarly article
main subject	wds:Q59649562-9222A5EB-84AF-4C0D-AAE3-0788F9014DDD wds:Q59649562-D8FB757E-AEF6-4327-AE46-92EFFC29BAA5
main subject	bladder cancer angiogenesis
PubMed ID	wds:Q59649562-AD04DB47-63C4-4B50-AE44-BCD0F95EC248
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20299037
PubMed ID	20299037
published in	wds:Q59649562-133CFD3F-6074-4D78-9257-087A59AE3429
published in	Journal of Urology
issue	wds:Q59649562-D15B9E6D-619F-4D56-A3C7-57DB7898A45F
volume	wds:Q59649562-7A8E220A-80CE-4F33-A967-FF389399DFA3
issue	5
volume	183
DOI	wds:Q59649562-DB70BC6C-5814-4B59-92CD-AE50DD48432D
DOI	http://dx.doi.org/10.1016/J.JURO.2010.01.018
DOI	10.1016/J.JURO.2010.01.018
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59649562
is cites work of	Molecular substratification of bladder cancer: moving towards individualized patient management The Fibroblast Growth Factor signaling pathway CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34. Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects Novel combination markers for predicting survival in patients with muscle invasive bladder cancer: USP18 and DGCR2. Urothelial carcinoma of the bladder: definition, treatment and future efforts Prognostic role of survivin in bladder cancer: a systematic review and meta-analysis Biomolecular predictors of urothelial cancer behavior and treatment outcomes Bladder cancer: a simple model becomes complex Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder Role of fibroblast growth factor in squamous cell carcinoma of the bladder: prognostic biomarker and potential therapeutic target Spotlight on differentially expressed genes in urinary bladder cancer. High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer. Angiogenesis in upper tract urothelial carcinoma associated with Balkan endemic nephropathy. Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma. Role of angiogenesis in urothelial bladder carcinoma RNA interference targeting adrenomedullin induces apoptosis and reduces the growth of human bladder urothelial cell carcinoma Prognostic Significance of Vascular Endothelial Growth Factor (VEGF) and Her-2 Protein in the Genesis of Cervical Carcinoma. ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer Thrombospondin-1-derived 4N1K peptide expression is negatively associated with malignant aggressiveness and prognosis in urothelial carcinoma of the upper urinary tract Impact of Preoperative Serum Albumin-Globulin Ratio on Disease Outcome After Radical Cystectomy for Urothelial Carcinoma of the Bladder Role of Non-Coding RNAs in the Etiology of Bladder Cancer. Performance of simultaneous high temporal resolution quantitative perfusion imaging of bladder tumors and conventional multi-phase urography using a novel free-breathing continuously acquired radial compressed-sensing MRI sequence CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer Antiangiogenesis to curb urothelial cancer. Invasion patterns and metastasis of urothelial carcinoma. A challenge for translational research
is cites work of	wds:Q38170812-2F7133BD-4AFF-4727-A38B-931C71E0418C wds:Q38435311-D45D3959-A82D-4D84-ABF4-9AE504D20365 wds:Q41616067-29357C70-5A46-4AE0-B300-0C810C73AA60 wds:Q36108115-1F0EF31A-4961-449A-BC53-AD67350598F8 wds:Q37944437-01B05633-625D-4945-B28A-7BA47A56293D wds:Q102060646-9850834C-FD37-4DAF-9070-9898C3FCEBC7 wds:Q37622196-EFAC809C-D52D-42B6-AD11-C2EE585814CF wds:Q35934764-A0AC0218-4C58-4AA5-ADA9-2305352F1FDB wds:Q35941467-DC1DAA7E-E090-44F3-91DE-3DECC7141040

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software